Evidence map›Paper›PMID 42256402›Full record

ArticleFrontiers in pharmacology2026

Morphological and complete genome analysis of a novel

Hamza Saghrouchni, Semra Tasdurmazli, Ibrahim Halil Kilic, Isil Var

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hamza SaghrouchniDepartment of Biotechnology, Institute of Natural and Applied Sciences, Çukurova University, Adana, Türkiye.
Semra TasdurmazliDepartment of Molecular Biology and Genetics, Yildiz Technical University, Istanbul, Türkiye.
Ibrahim Halil KilicDepartment of Biology, Faculty of Arts and Sciences, Gaziantep University, Gaziantep, Türkiye.
Isil VarDepartment of Food Engineering, Engineering Faculty, Çukurova University, Adana, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Various systemic and enteric diseases have been attributed to Methods: In this study, a novel lytic Results: Transmission electron microscopy (TEM) analysis revealed that CpP_VarHS possesses a short, non-contractile tail (31.55 ± 2.5 nm in length) and a regular icosahedral head (44.23 ± 2.1 nm in diameter), characteristic of the podovirus morphotype. Whole-genome analysis showed that the CpP_VarHS genome is 17,814 bp long, linear double-stranded DNA with a GC content of 28.30%. Among the 21 identified open reading frames, 12 were functional genes (GenBank accession number PP973485). Whole-genome sequence comparison showed 94.37% and 94.31% nucleotide identity with Conclusion: To the best of our knowledge, this is the first report of the isolation of a

Indexed as

antibacterial activityClostridium perfringenslytic bacteriophagemolecular sequencingphage therapytransmission electron microscope

Identifiers

PMID42256402
PMCPMC13236511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.